Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Magnolia kobus
Japanese magnolia tree with white flowers used in traditional Japanese Kampo medicine for sinus conditions.
Magnolia kobus is a tree used in traditional Japanese Kampo medicine for sinusitis and headaches. Modern research indicates potential as a nasal decongestant, anti-inflammatory, and antimicrobial agent, attributed to bioactive compounds such as magnolol, honokiol, and salicylaldehyde. Evidence is limited (Grade C), primarily from in vitro and small clinical studies.
Magnolol and honokiol inhibit nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2), reducing pro-inflammatory cytokines. They also exhibit GABA-A receptor modulation, contributing to anxiolytic and sedative effects. Salicylaldehyde provides analgesic and antipyretic activity via COX inhibition. Antimicrobial action involves disruption of bacterial cell membranes and inhibition of biofilm formation. Nasal decongestion may result from anti-inflammatory effects on nasal mucosa and mild vasoconstriction.
Japanese magnolia tree with white flowers used in traditional Japanese Kampo medicine for sinus conditions.
Magnolia kobus is a tree used in traditional Japanese Kampo medicine for sinusitis and headaches. Modern research indicates potential as a nasal decongestant, anti-inflammatory, and antimicrobial agent, attributed to bioactive compounds such as magnolol, honokiol, and salicylaldehyde. Evidence is limited (Grade C), primarily from in vitro and small clinical studies.
Magnolol and honokiol inhibit nuclear factor-kappa B (NF-κB) and cyclooxygenase-2 (COX-2), reducing pro-inflammatory cytokines. They also exhibit GABA-A receptor modulation, contributing to anxiolytic and sedative effects. Salicylaldehyde provides analgesic and antipyretic activity via COX inhibition. Antimicrobial action involves disruption of bacterial cell membranes and inhibition of biofilm formation. Nasal decongestion may result from anti-inflammatory effects on nasal mucosa and mild vasoconstriction.